
LHDXQ
Healthcare · Medical Devices
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 10, 2023 | Time not confirmed | -0.87 | 0.00 | +100.0% |
| May 11, 2023 | Time not confirmed | -0.07 | 0.00 | +100.0% |
| Mar 30, 2023 | Before the open | -0.07 | -0.33 | -371.4% |
| Nov 14, 2022 | After the close | -0.38 | -3.15 | -728.9% |
| Aug 15, 2022 | After the close | -0.34 | -0.45 | -32.4% |
| May 12, 2022 | After the close | -0.08 | 0.40 | +600.0% |
| Mar 10, 2022 | After the close | -0.55 | 0.01 | +101.8% |
| Nov 11, 2021 | After the close | -0.51 | -0.47 | +7.8% |
| Aug 12, 2021 | After the close | -0.32 | -0.38 | -18.8% |
| May 13, 2021 | After the close | -0.33 | -0.54 | -63.6% |
| Feb 5, 2021 | After the close | -0.80 | -0.45 | +43.9% |
Lucira Health, Inc. is in the process of liquidation. Previously, the company engaged in the development and commercialization of infectious disease test kits. It developed a testing platform that produces molecular testing services. The company offered LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical…